INTRODUCTION
============

Caspases are enzymes orchestrating the cellular pathways leading to apoptosis and inflammatory signals. Besides these functions they are supposed to be involved in other cellular processes, such as development, cell cycle, cell proliferation, cell migration and receptor internalization ([@b1],[@b2]). Caspases are cysteine proteases with specificity for an aspartic acid residue at position P1 of the substrate. This primary specificity is shared by the serine protease granzyme B, which induces cytotoxic T lymphocyte-mediated target cell DNA fragmentation and apoptosis ([@b3],[@b4]). Granzyme B-mediated cleavage also plays a role in induction of autoimmunity ([@b5]).

To date, at least 14 mammalian caspases can be grouped into three classes based on their substrate specificities. Group I consisting of caspases -1, -4, -5 (-14 and murine -11 and -12) cleaves the substrate sequence (W/L)EHD, group II (caspases -2, -3, -7) cleaves the DEXD motif and group III (caspase -6, -8, -9, -10) preferentially cleaves the (L/V)E(T/H)D sequence ([@b6],[@b7]). Caspases of group I play an important role in the generation of inflammatory signals and in the immune regulation. Caspases -8, -9 and -10 are so-called initiator caspases mainly cleaving and activating procaspases, whereas caspases -3, -6 and -7 as effector caspases cleave numerous cellular proteins. The serine protease granzyme B prefers substrates with sequence IEXD, and is released by cytotoxic lymphocytes to kill virus-infected or tumor cells.

Although more than 280 caspase targets are described \[for comprehensive review see ([@b8])\] many substrates still await identification and many cleavage sites of known substrates are not identified or experimentally verified. Likewise, the identification of granzyme B substrates is still at its infancy. Intracellular substrates of granzyme B include other caspases, mainly caspase 3 ([@b9]), ADPRT (ADP-ribosyltransferase 1, PARP) ([@b10]), BID (BH3 interacting domain death agonist) ([@b11]) and ICAD (DNA fragmentation factor) ([@b12]). Notably, the majority of autoantigens in systemic autoimmune diseases are efficiently cleaved by granzyme B ([@b5]).

A more comprehensive knowledge of caspase and granzyme B substrates is essential to understand the biological roles of these enzymes in more detail. The relatively high variability in cleavage site recognition sequence often complicates the identification of cleavage sites. As of yet there is no software available that allows identification of caspase and/or granzyme cleavage sites differing from the consensus sequence. The PeptidCutter program provided by the ExPasy Server (<http://www.expasy.org/tools/peptidecutter>) considers only the preferred peptide substrate sites. A recent tool of Lohmüller *et al*. ([@b13]) is restricted to caspase 3 and cathepsin B and -L substrates. Here, we present a bioinformatics tool GraBCas that provides score-based prediction of potential cleavage sites for the caspases 1--9 and granzyme B including an estimation of the fragment size. We validated our tool by scoring known substrates and demonstrated its usefulness for protein sequence analysis.

MATERIALS AND METHODS
=====================

Design of cleavage site scoring matrices
----------------------------------------

We developed position specific scoring matrices (PSSM) for the endopeptidases granzyme B and caspase 1--9 based on experimentally determined substrate specificities ([@b6]). Thornbery *et al*. ([@b6]) determined the substrate specificities using positional scanning synthetic combinatorial libraries. Cleavage was fluorimetrically determined with maximum value annotated with 100 and the values for the remaining amino acids given as percentage of the observed maximum rate. These experimental values provided the basis for creating our PSSM.

The values for each amino acid at position P*i* are shown in [Table 1](#tbl1){ref-type="table"}. For a better readability we decided to set the maximum values to 1000 instead of 100 and adjusted the other values accordingly. For each endopeptidase the scores of the amino acids were entered in a 3 × 20 matrix. The rows of such a matrix correspond to positions P4, P3 or P2 of a possible cleavage site. Each column represents one amino acid and contains the relative frequencies of the amino acid measured in the study of Thornbery *et al*. ([@b6]). We are working with PSSM that can be interpreted as probability matrices. Since probabilities of value 0 should be avoided in such probability-based position scores, all entries of experimental relative frequencies with value 0 were set to 1. The amino acids cysteine and methionine were not part of the study of Thornbery *et al*. ([@b6]). The entries for these amino acids were also set to 1 in [Table 1](#tbl1){ref-type="table"}.

Computing the scores of endopeptidase cleavage sites
----------------------------------------------------

For computing the score, the GraBCas program screens for tetrapeptides with Asp (D) at their last position (P1) in a given amino acid sequence. Given the tetrapeptide A4A3A2D (≈P4P3P2P1) of a potential cleavage site, its score for a given endopeptidase is computed by multiplying the corresponding matrix entries of A2 at position P2, A3 at position P3 and A4 at position P4. The product is divided by the value (1000^3^) of the product of the consensus recognition motif for normalization and multiplied by 100, yielding a total score between 0 and 100. $$\begin{matrix}
{\text{Score}\left( \text{A}4\text{A}3\text{A}2\text{D} \right)} \\
{\quad = 100 \times \frac{\text{Score}_{\text{P4}}\left( \text{A4} \right) \times \text{Score}_{\text{P3}}\left( \text{A3} \right) \times \text{Score}_{\text{P2}}\left( \text{A2} \right)}{1000^{3}}.} \\
\end{matrix}$$

Using additional filter options for granzyme B and caspase 3
------------------------------------------------------------

To improve the power of the prediction we analyzed the amino acid distribution of known granzyme B and caspase 3 cleavage sites at positions P6--P2′ taken from the literature (see also Supplementary Material 1 and 2).

For granzyme B we found a preference for V (15×) and I (11×) at position P4, for E (9×) at position P3 and for P (11×) at position P2 in accordance with the results of Thornberry *et al*. ([@b6]). We detected S at position P1′ and G at position P2′, respectively in 9 out of 30 cleavage sites. The result list of the PSSM-based cleavage sites can optionally be filtered with two 'stringency' filters that take the occurrence of amino acids at position P2′ into account. We installed a 'low stringency' filter that excludes hits with the amino acids C, Q, I, M, V all of which are medium sized or large amino acids. A second 'high stringency' filter selects hits with a G at position P2′.

The analysis of the 59 cleavage sites of caspase 3 substrate confirmed the preferences for D at P4 (31×), E at P3 (17×) and V at P2 (16×). For P1′ we found an abundance of G (18×) and S (17×) and in lower amount A (5×) and N (4×). As for the granzyme B prediction, two additional 'stringency' filters for the prediction of caspase 3 cleavage sites are available. The 'high stringency' filter screens the predicted hits for occurrences of G, S, A or N at position P1′, and the 'low stringency' filter screens for absence of R, E, H, K, Q, I, L, M, F, W and Y at this position.

GraBCas software tool
---------------------

The GraBCas program was written in Java™ and is available as an application or as an applet. Both are available at <http://wwwalt.med-rz.uniklinik-saarland.de/med_fak/humangenetik/software/index.html>. If your browser does not support Java™ you need to install the Java Runtime Environment (JRE) 1.4.x, which can be downloaded at <http://java.sun.com>.

The graphical user interface is easy to use. There are several register cards for each endopeptidase and one register card presenting the input form, where the amino acid sequence can be pasted and a cutoff for the PSSM scores can be chosen. After pressing the OK-button in the input form, the program calculates the scores of potential cleavage sites for all endopeptidases and presents them in the corresponding register card sorted with the highest scoring sites on top. The user can open an additional window for viewing the positions of the predicted cleavage sites within the amino acid sequence. The window also shows the fragment length and size in kDa (0.11 kDa per amino acid) of the predicted fragments.

As described above, for caspase 3 and granzyme B additional filter options are available in their register cards. The two filter types for these enzymes, a 'high-stringency' and a 'low-stringency' filter, are based on the extended substrate specificity. For granzyme B the amino acids at position P2′ were taken into account in addition to the positions P4--P1. For caspase 3, amino acids at position P1′ are evaluated.

Sensitivity--specificity plots
------------------------------

For determining the specificity and sensitivity of the GraBCas predictions we used the known cleavage sites of granzyme B ([@b4]--[@b6],[@b9]--[@b12]) summarized in [Table 2](#tbl2){ref-type="table"} and the known non-substrates of granzyme B ([@b5]) presented in [Table 4](#tbl4){ref-type="table"}. Due to the lack of information on known non-substrates for caspase 3 the sensitivity--specificity plot could only be calculated for granzyme B ([Figure 1](#fig1){ref-type="fig"}).

The *x*-axis of the plots represents the cutoff values (with respect to the PSSM scores), while the *y*-axis represents the percentage of the specificity or sensitivity of the predictions made by GraBCas, respectively. The specificity is computed as follows: $$\frac{\text{Number\ of\ true\ negatives}}{\text{Number\ of\ false\ positives} + \text{Number\ of\ true\ negatives}}.$$

The true negatives are the known non-substrates where the maximal PSSM score of all tetrapeptides ending with a D is smaller than the chosen cutoff value. A specificity of 1 means that all known non-substrates were below the cutoff, i.e. all known non-substrates were correctly classified as negatives.

The sensitivity is defined as: $$\frac{\text{Number\ of\ true\ positives}}{\text{Number\ of\ true\ positives} + \text{Number\ of\ false\ negatives}},$$ where true positives are the known cleavage sites with a score larger than the chosen cutoff value. A sensitivity of 1 means that all cleavage sites of our test set ([Table 2](#tbl2){ref-type="table"}) have a score higher than the chosen cutoff and that they have been correctly classified as positives.

RESULTS AND DISCUSSION
======================

We analyzed the cleavage sites of known substrates of granzyme B and caspase 3 to compare the experimentally identified peptide specificity with the cleavage site predicted by the program GraBCas.

In total, we collected 29 substrates with 30 cleavage sites for granzyme B ([Table 2](#tbl2){ref-type="table"}) and 47 substrates with 59 cleavage sites for caspase 3 ([Table 3](#tbl3){ref-type="table"}) and computed the GraBCas scores of the cleavage sites. For granzyme B we collected additionally 17 sequences which are non-substrates of this endopeptidase ([Table 4](#tbl4){ref-type="table"}), computed the scores of all putative cleavage sites in these sequences and extracted the best hit by GraBCas for each of these non-substrates.

The sensitivity--specificity plot for granzyme B is shown in [Figure 1](#fig1){ref-type="fig"}. When using a cutoff value of 1.2 in the GraBCas program, we obtain a sensitivity of ∼80% and a specificity of ∼82%. The cutoff value can be adjusted if a higher specificity or sensitivity is needed for the cleavage site prediction.

A closer look at the sensitivity--specificity plot shows that the best score (28.8 for IEED in glycogen phosphorylase) of the alleged non-substrates is extremely high. The top value of the best hit IEED is due to the fact that this tetrapeptide has three identical positions with the granzyme B consensus recognition motif IEPD. Furthermore, the amino acid E on P2 has a middle-sized value and the tetrapeptides LEED, IEAD and IETD are known substrates of granzyme B. We assume that glycogen phosphorylase is probably a substrate of granzyme B. This warrants further experimental analysis.

We also studied the occurrences of amino acids at position P1′ and P2′ of the known cleavage sites of granzyme B and caspase 3. Additional filtering options have been added to GraBCas that are based on these statistics. For granzyme B, we detected G at position P2′ in 9/30 cleavage sites. This confirms the results of Harris *et al*. ([@b14]), who found for recombinant rat granzyme B a specificity for G at P2′. We did not, however, confirm the proposed total absence of charged amino acids at P1′, in that we found E three times, R two times and K and D one time, each.

For caspase 3, we found in total 44/59 (75%) cleavage sites with G, S, A or N at position P1′. These results are in good accordance with the results of Stennicke *et al*. ([@b15]). Absent amino acids included the charged residues R, E, H, K and the large residues Q, I, L, M, F, W and Y.

With GraBCas we provide a position specific scoring scheme for the prediction of cleavage sites for granzyme B and caspases 1--9. GraBCas offers an easy to use, concise user interface in register card format. The design of GraBCas specifically acknowledged the high variability of cleavage site recognition sequences. We validated our tool by scoring known substrates and demonstrated its usefulness for protein sequence analysis. GraBCas may contribute to a more comprehensive knowledge of caspase and granzyme B substrates and a better understanding of the biological roles of these enzymes.

SUPPLEMENTARY MATERIAL
======================

Supplementary Material is available at NAR Online.
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![Sensitivity--specificity plot for granzyme B. *x*-axis: scores by the GraBCas program; *y*-axis: percentage of specificity or sensitivity.](gki433f1){#fig1}

###### 

Scoring matrices for granzyme B and caspases 1--9

               Position P*i*   AA of consensus recognition motif   C   S     T      P      A     G     N     D      E      Q     H      R     K     M   I      L      V      F     Y     W
  ------------ --------------- ----------------------------------- --- ----- ------ ------ ----- ----- ----- ------ ------ ----- ------ ----- ----- --- ------ ------ ------ ----- ----- ------
  Granzyme B   4               I                                   1   1     1      1      1     1     1     1      1      1     1      1     1     1   1000   52     500    12    1     1
               3               E                                   1   297   54     1      153   477   1     198    1000   81    9      1     1     1   1      1      1      1     1     9
               2               P                                   1   752   544    1000   576   16    624   144    288    576   544    1     1     1   16     96     304    144   16    16
  Caspase 1    4               W                                   1   48    48     48     48    16    16    80     96     16    128    1     1     1   96     288    80     496   576   1000
               3               E                                   1   357   442    1      442   425   119   374    1000   646   187    51    34    1   221    323    442    272   187   85
               2               H                                   1   144   396    144    180   18    72    36     72     108   1000   54    72    1   198    54     108    126   144   126
  Caspase 2    4               D                                   1   1     50     10     1     1     10    1000   200    1     1      1     1     1   180    400    80     40    40    1
               3               E                                   1   425   884    1      680   119   119   102    1000   680   153    408   221   1   119    187    646    255   187   153
               2               H                                   1   624   528    352    336   48    96    1      1      16    1000   320   304   1   144    16     80     16    16    80
  Caspase 3    4               D                                   1   40    50     1      10    1     20    1000   40     1     10     1     1     1   10     1      20     10    1     1
               3               E                                   1   306   357    1      357   85    153   255    1000   408   187    17    17    1   153    153    306    272   255   119
               2               V                                   1   14    378    406    182   1     14    1      0      14    196    42    0     1   714    224    1000   182   154   84
  Caspase 4    4               W                                   1   80    208    144    96    48    80    288    256    96    48     1     1     1   304    848    224    384   352   1000
               3               E                                   1   187   119    34     119   17    85    221    1000   306   85     1     17    1   51     85     204    187   85    17
               2               H                                   1   102   119    119    425   17    102   221    357    153   1000   51    1     1   595    17     119    85    102   51
  Caspase 5    4               W                                   1   14    56     1      56    126   42    98     98     84    56     1     1     1   280    1000   154    504   406   1000
               3               E                                   1   24    12     1      12    1     1     124    1000   12    12     1     1     1   12     12     12     12    12    1
               2               H                                   1   340   425    323    323   1     85    119    323    85    1000   17    34    1   272    17     272    153   204   102
  Caspase 6    4               V                                   1   144   880    64     96    16    64    224    256    48    48     1     1     1   656    304    1000   80    48    48
               3               E                                   1   48    48     16     80    16    16    176    1000   144   48     1     1     1   16     16     48     48    16    48
               2               H                                   1   54    576    18     72    18    108   18     18     36    1000   54    36    1   648    486    918    288   216   558
  Caspase 7    4               D                                   1   117   78     1      39    26    26    1000   104    26    39     1     1     1   13     1      13     13    13    1
               3               E                                   1   221   357    1      323   51    153   255    1000   425   187    85    102   1   306    221    697    204   204   102
               2               V                                   1   16    448    448    128   16    48    1      1      16    208    80    16    1   704    176    1000   160   128   48
  Caspase 8    4               L                                   1   208   304    480    448   96    304   704    448    96    144    1     1     1   576    1000   720    224   256   144
               3               E                                   1   45    75     0      45    15    15    180    1000   150   45     1     1     1   45     15     105    45    45    15
               2               T                                   1   180   1000   216    324   18    126   72     198    108   306    72    72    1   720    108    792    180   198   306
  Caspase 9    4               L                                   1   198   216    594    576   144   108   414    468    180   126    36    18    1   576    1000   684    252   216   144
               3               E                                   1   85    136    51     85    17    17    272    1000   187   119    1     17    1   102    119    204    102   85    51
               2               H                                   1   85    136    102    85    17    17    51     34     17    1000   34    1     1   187    17     153    51    34    51

Amino acid preference distribution for each position P*i* was extracted from Thornberry *et al*. ([@b6]) giving the most common amino acid a value of 1000.

###### 

Analysis of cleavage sites of known granzyme B substrates with GraBCas

  Granzyme B substrate                                                       Acc_number   Known cleavage site   Score by GraBCas   P6--P2′ of cleavage site
  -------------------------------------------------------------------------- ------------ --------------------- ------------------ --------------------------
  AARS: alanyl-tRNA synthetase                                               NP_001596    VADP (632)            7,65               `SLVAPDRL`
  ADPRT: ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)         NP_001609    VDPD (536)            9,9                `AAVDPDSG`
  BID: BH3 interacting domain death agonist                                  NP_001187    IEAD (75)             57,6               `GRIEADSE`
  CASP3: caspase 3, apoptosis-related cysteine protease                      NP_004337    IETD (175)            54,4               `CGIETDSG`
  CASP7: caspase 7, apoptosis-related cysteine protease                      NP_001218    IQAD (198)            4,6656             `DGIQADSG`
  CENPB: centromere protein B, 80 kDa                                        NP_001801    VDSD (457)            7,4448             `GDVDSDEE`
  CHD4: chromodomain helicase DNA binding protein 4                          NP_001264    VDPD (1312)           9,9                `ESVDPDYW`
  DFFA: DNA fragmentation factor, 45 kDa, alpha polypeptide                  NP_004392    DETD (117)            0,0544             `MEVTGDAG`
  DFFA: DNA fragmentation factor, 45 kDa, alpha polypeptide                  NP_004392    VTGD (6)              0,0432             `DVDETDSG`
  FBL: fibrillarin                                                           NP_001427    VGPD (184)            23,85              `DIVGPDGL`
  FLNA: filamin A, alpha (actin binding protein 280)                         NP_001447    ?                     11,4048            `TEIDQDKY`
  G22P1: thyroid autoantigen 70 kDa (Ku antigen)                             NP_001460    ISSD (79)             22,3344            `KIISSDRD`
  GRIA3: glutamate receptor, ionotrophic, AMPA 3                             NP_000819    ISND (416)            18,5328            `QQISNDSA`
  HARS: histidyl-tRNA synthetase                                             NP_002100    LGPD (48)             2,4804             `AQLGPDES`
  IARS: isoleucine-tRNA synthetase                                           NP_002152    VTPD (983)            2,7                `LDVTPDQS`
  L4 100K \[Human adenovirus C\]                                             AAQ19301     IEQD (48)             57,6               `VIIEQDPG`
  MKI67: antigen identified by monoclonal antibody Ki-67                     NP_002408    VCTD (1481)           0,0272             `TPVCTDKP`
  NUMA1: nuclear mitotic apparatus protein 1                                 NP_006176    VATD (1705)           4,1616             `FQVATDAL`
  PMS1: PMS1 postmeiotic segregation increased 1                             NP_000525    ISAD (496)            17,1072            `SEISADEW`
  PMS2: PMS2 postmeiotic segregation increased 2                             NP_000526    VEKD (493)            0,05               `AEVEKDSG`
  PMSCL2: polymyositis/scleroderma autoantigen 2, 100 kDa                    NP_002676    VEQD (252)            28,8               `QQVEQDMF`
  POLR1A: polymerase (RNA) I polypeptide A, 194 kDa                          NP_056240    ICPD (448)            0,1                `SVICPDMY`
  POLR2A: polymerase (RNA) II (DNA directed) polypeptide A, 220 kDa          NP_000928    ITPD (370)            5,4                `TVITPDPN`
  PRKDC: protein kinase, DNA-activated, catalytic polypeptide                NP_008835    VGPD (2698)           23,85              `KSVGPDFG`
  SNRP70: small nuclear ribonucleoprotein 70 kDa polypeptide (RNP antigen)   NP_003080    LGND (409)            1,5477696          `EGLGNDSR`
  SRP72: signal recognition particle 72 kDa                                  NP_008878    VTPD (573)            2,7                `PKVTPDPE`
  SSB: Sjogren syndrome antigen B (autoantigen La)                           NP_003133    LEED (220)            1,4976             `QKLEEDAE`
  TOP1: topoisomerase (DNA) I                                                NP_003277    IEAD (15)             57,6               `SQIEADFR`
  UBE4B: ubiquitination factor E4B (UFD2 homolog, yeast)                     NP_006039    VDVD (123)            3,0096             `SQVDVDSG`
  UBTF: upstream binding transcription factor, RNA polymerase I              NP_055048    VRPD (220)            0,05               `LKVRPDAT`

The bold printed amino acids in the extended cleavage site indicate hits with a G residue at position P2′ detected by the high stringency filter. Numbers in brackets indicate cleavage site position in the amino acid sequence.

###### 

Analysis of cleavage sites of known caspase 3 substrates with GraBCas

  Caspase 3 substrate                                                                           Acc_number   Known cleavage site   Score by GraBCas   P6--P2′ of cleavage site
  --------------------------------------------------------------------------------------------- ------------ --------------------- ------------------ --------------------------
  ADD1: adducing 1 (alpha)                                                                      NP_001110    DDSD (633)            0,357              `TGDDSDAA`
  APAF1: apoptotic protease activating factor                                                   NP_001151    SVTD (271)            0,462672           `DKSVTDSV`
  ARHGDIB: Rho GDP dissociation inhibitor (GDI) beta                                            NP_001166    DELD (19)             22,4               `DDDELDSK`
  ATP2B4: ATPase, Ca++ transporting, plasma membrane 4                                          NP_001675    DEID (1080)           71,4               `GLDEIDHA`
  BAD: BCL2-antagonist of cell death                                                            NP_004313    EQED (14)             0,001632           `PSEQEDSS`
  BAX: BCL2-associated X protein                                                                NP_004315    FIQD (33)             0,002142           `QGFIQDRA`
  BCL2: B-cell CLL/lymphoma 2                                                                   NP_000624    DAGD (34)             0,0357             `EWDAGDVG`
  BCL2L1: BCL2-like 1                                                                           NP_001182    HLAD (61)             0,027846           `SWHLADSP`
  BCL2L1: BCL2-like 2                                                                           NP_001182    SSLD (76)             0,274176           `HSSSLDAR`
  BIRC2: baculoviral IAP repeat-containing 2                                                    NP_001157    ENAD (372)            0,111384           `GEENADPP`
  BLM: Bloom syndrome                                                                           NP_000048    TEVD (415)            5                  `LLTEVDFN`
  BRCA1: breast cancer 1, early onset                                                           NP_009225    DLLD (1154)           3,4272             `PDDLLDDG`
  CAMK4: calcium/calmodulin-dependent protein kinase IV                                         NP_001735    YWID (31)             0,0084966          `PDYWIDGS`
  CAMK4: calcium/calmodulin-dependent protein kinase IV                                         NP_001735    PAPD (176)            0,0144942          `ATPAPDAP`
  CDC2L1: cell division cycle 2-like 1 (PITSLRE proteins)                                       NP_001778    YVPD (391)            0,0124236          `GDYVPDSP`
  CDC6: CDC6 cell division cycle 6 homolog (*Saccharomyces cerevisiae*)                         NP_001245    SEVD (442)            4                  `VISEVDGN`
  CDC6: CDC6 cell division cycle 6 homolog (*S.cerevisiae*)                                     NP_001245    LVRD (99)             0,0055692          `RRLVFDNQ`
  CDKN1A: cyclin-dependent kinase inhibitor 1A (p21, Cip1)                                      NP_000380    DHVD (112)            18,7               `EEDHVDLS`
  CSEN: calsenilin, presenilin binding protein, EF hand transcription factor                    NP_038462    DSSD (64)             0,4284             `GSDSSDSE`
  CTNNB1: catenin (cadherin-associated protein), beta 1, 88 kDa                                 NP_001895    DLMD (764)            0,0153             `AQDLMDGL`
  CTNNB1: catenin (cadherin-associated protein), beta 1, 88 kDa                                 NP_001895    YPVD (751)            10                 `ADYPVDGL`
  CTNNB1: catenin (cadherin-associated protein), beta 1, 88 kDa                                 NP_001895    ADID (83)             0,18207            `QVADIDGQ`
  CTNNB1: catenin (cadherin-associated protein), beta 1, 88 kDa                                 NP_001895    TQFD (115)            0,37128            `PSTQFDAA`
  CTNNB1: catenin (cadherin-associated protein), beta 1, 88 kDa                                 NP_001895    SYLD (32)             0,22848            `QQSYLDSG`
  DFFA: DNA fragmentation factor, 45 kDa, alpha polypeptide                                     NP_004392    DAVD (224)            35,7               `EVDAVDTG`
  DFFA: DNA fragmentation factor, 45 kDa, alpha polypeptide                                     NP_004392    DETD (117)            37,8               `DVDETDSG`
  DRPLA: dentatorubral-pallidoluysian atrophy (atrophin-1)                                      NP_001931    DSLD (109)            6,8544             `DLDSLDGR`
  EIF2S1: eukaryotic translation initiation factor 2, subunit 1 alpha, 35 kDa                   NP_004085    AEVD (301)            1                  `ENAEVDGD`
  EIF2S1: eukaryotic translation initiation factor 2, subunit 1 alpha, 35 kDa                   NP_004085    DGDD (304)            0,0085             `EVDGDDDA`
  FNTA: farnesyltransferase, CAAX box, alpha                                                    NP_002018    VSLD (59)             0,137088           `GFVSLDSP`
  GCLC: glutamate-cysteine ligase, catalytic subunit                                            NP_001489    AVVD (499)            0,306              `GNAVVDGC`
  GSN: gelsolin (amyloidosis, Finnish type)                                                     NP_000168    DQTD (403)            15,4224            `DPDQTDGL`
  HD: huntingtin (Huntington disease)                                                           NP_002102    DSVD (513)            30,6               `WEAQRDSH`
  HNRPU: heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)               NP_004492    SALD (100)            0,319872           `GISALDGD`
  IL16: interleukin 16 (lymphocyte chemoattractant factor)                                      NP_004504    SSTD (510)            0,462672           `LNSSTDSA`
  IL18: interleukin 18 (interferon-gamma-inducing factor)                                       NP_001553    LESD (36)             0,0014             `ENLESDYF`
  KRT18: keratin 18                                                                             NP_000215    VEVD (238)            2                  `LTVEVDAP`
  MAPT: microtubule-associated protein tau                                                      NP_005901    DMVD (421)            0,1                `SIDMVDSP`
  MDM2: Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)                 NP_002383    DVPD (361)            12,4236            `GFDVPDCK`
  NFKBIA: nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha   NP_065390    DRHD (32)             0,3332             `LDDRHDSG`
  NUMA1: nuclear mitotic apparatus protein 1                                                    NP_006176    DSLD (1712)           6,8544             `SIDSLDLS`
  PAK2: p21 (CDKN1A)-activated kinase 2                                                         NP_002568    SHVD (212)            0,748              `GDSHVDGA`
  POLE: polymerase (DNA directed), epsilon                                                      NP_006222    DQLD (189)            9,1392             `IADQLDNI`
  POLE: polymerase (DNA directed), epsilon                                                      NP_006222    DMED (1185)           10                 `APDMEDFG`
  PPP2R1A: protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform     NP_055040    DEQD (218)            1,4                `ASDEQDSV`
  PRKCD: protein kinase C, delta                                                                NP_006245    DMQD (329)            0,0014             `GEDMQDNS`
  PRKCM: protein kinase C, mu                                                                   NP_002733    CQND (378)            5,712              `AECQNDSG`
  PRKCQ: protein kinase C, theta                                                                NP_006248    DEVD (354)            100                `PLDEVDKM`
  PRKCZ: protein kinase C, zeta                                                                 NP_002735    DGVD (239)            0,0085             `VIDGMDGI`
  PRKCZ: protein kinase C, zeta                                                                 NP_002735    EETD (210)            1,512              `PSEETDGI`
  PRKDC: protein kinase, DNA-activated, catalytic polypeptide                                   NP_008835    DEVD (2713)           100                `PGDEVDNK`
  PSEN2: presenilin 2 (Alzheimer disease 4)                                                     NP_000438    DSYD (329)            4,7124             `EEDSYDSF`
  RB1: retinoblastoma 1 (including osteosarcoma)                                                NP_000312    DEAD (886)            18,2               `GSDEADGS`
  RFC1: replication factor C (activator 1) 1, 145 kDa                                           NP_002904    DEVD (722)            100                `IMDEVDGM`
  ROCK1: Rho-associated, coiled-coil containing protein kinase 1                                NP_005397    DETD (1113)           37,8               `SADETDGN`
  SNRP70: small nuclear ribonucleoprotein 70 kDa polypeptide (RNP antigen)                      NP_003080    DGPD (341)            3,451              `GPDGPDGP`
  SPTBN1: spectrin, beta, non-erythrocytic 1                                                    NP_003119    DEVD (1457)           100                `STDEVDSK`
  SPTBN1: spectrin, beta, non-erythrocytic 2                                                    NP_003119    ETVD (2146)           1,428              `MAETVDTS`
  VIM: vimentin                                                                                 NP_003371    DSVD (85)             30,6               `KGDEVDGV`

The bold printed amino acids in the extended clevage site indicate hits detected by the high stringency filter. Numbers in brackets indicate clevage site position in the amino acid sequence.

###### 

Analysis of cleavage sites of known non-substrates of granzyme B with GraBCas

  Granzyme B non-substrate                                                                                       Acc_number     Best hit     Score by GraBCas
  -------------------------------------------------------------------------------------------------------------- -------------- ------------ ------------------
  TRIM21: 52 kD Ro/SSA autoantigen                                                                               NP_003132      LDPD (294)   1,0296
  SSA2: 60 kD Ro/SSA autoantigen                                                                                 NP_004591      VTTD (427)   1,4688
  XRCC5: ATP-dependent DNA helicase II Ku80                                                                      NP_066964      FGTD (62)    0,3113856
  VCL: vinculin isoform VCL                                                                                      NP_003364      LQSD (98)    0,3167424
  VCL: vinculin isoform meta-VCL                                                                                 NP_054706      LQSD (98)    0,3167424
  TUBB2: tubulin, beta 2                                                                                         NP_001060      VISD (26)    0,0376
  CRP: C-reactive protein, pentraxin-related                                                                     NP_000558      LSPD (187)   1,5444
  SERPINA1: serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1   NP_000286      LAED (26)    0,2291328
  SERPINA1: serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1   NP_001002235   LAED (26)    0,2291328
  SERPINA1: serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1   NP_001002236   LAED (26)    0,2291328
  GSTA1: glutathione *S*-transferase A1                                                                          NP_665683      VEID (61)    0,8
  PYGB: brain glycogen phosphorylase                                                                             NP_002853      IEED (129)   28,8
  TF: transferring                                                                                               NP_001054      VTLD (82)    0,2592
  LTF: lactotransferrin                                                                                          NP_002334      VTLD (79)    0,2592
  LYZ: lysozyme precursor                                                                                        NP_000230      RSTD (71)    0,0161568
  ORM1: orosomucoid 1 precursor                                                                                  NP_000598      LAFD (133)   0,1145664
  F2: coagulation factor II precursor (Thrombin B-chain)                                                         NP_000497      LDED (306)   0,2965248

Numbers in brackets indicate cleavage site position in the amino acid sequence.

[^1]: The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint First Authors
